KLISBio
Financiado
Silk fibroin tissue grafting for peripheral nerve repair
Peripheral nerve injury is a major source of disability, impairing muscle movement or normal sensations: 4Mn people annually experience traumatic nerve damage. Current solutions do not always achieve full motor and sensory recover...
Peripheral nerve injury is a major source of disability, impairing muscle movement or normal sensations: 4Mn people annually experience traumatic nerve damage. Current solutions do not always achieve full motor and sensory recovery, leading to loss of sensation/function and pain, with a significant impact to patients’ lives. With 50% unsuccessful nerve repair procedures, patients require prolonged rehabilitation, and 30% of them experience permanent disability, producing a high socio-economic burden. KLISBio has developed SILKBridge, a novel cost-effective nerve guide made of silk fibroin for safe and efficient peripheral nerve repair. KLISBio’s solution, clinically tested with a first in human (FIH) study, supports and protects the regenerating nerve from compressive forces, restoring its function, and reducing pain without patient discomfort. SILKBridge enhances nerve healing without immune rejection nor fibrosis, reducing the costs of rehabilitation and prolonged surgeries.
ver más
Duración del proyecto: 23 meses
Fecha Inicio: 2024-07-01
Fecha Fin: 2026-06-30
Fecha Fin: 2026-06-30
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-07-01
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2023-ACCELERATOROPEN-01:
EIC Accelerator Open 2023
Cerrada
hace 1 año
Presupuesto
El presupuesto total del proyecto asciende a
4M€
Líder del proyecto
SILK BIOMATERIALS SRL
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5